Media formats available:
Recommended
- Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibitionRemaining questions on SGLT2 inhibition & CKD: A review of new outcome trials
Prof. Colin Baigent
- Diabetic Kidney Disease: Exploring mechanisms and outcomes of SGLT2 inhibitionSGLT2 inhibition in kidney disease: key lessons from EMPA-REG OUTCOME
Prof. Christoph Wanner